skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,654  for All Library Resources

Sorted by: Sorted by: Date-oldestOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: subject: Clinical Trials remove Business Wire remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Guidant Completes Enrollment in International Drug Eluting Stent Clinical Trial; Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States
Guidant Completes Enrollment in International Drug Eluting Stent Clinical Trial; Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States
Material Type:
Newspaper Article 		Add to My Research

Guidant Completes Enrollment in International Drug Eluting Stent Clinical Trial; Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States

Business Wire, 2005-11-10

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
2
Data from Three New AutoPulse Clinical Studies to be Presented at the American Heart Association Meeting
Data from Three New AutoPulse Clinical Studies to be Presented at the American Heart Association Meeting
Material Type:
Newspaper Article 		Add to My Research

Data from Three New AutoPulse Clinical Studies to be Presented at the American Heart Association Meeting

Business Wire, 2005-11-11

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
3
Anaclim, LLC, A New Contract Research Organization (CRO) Designed to Help Address Chronically Under-Represented Ethnic Minorities in Clinical Research
Anaclim, LLC, A New Contract Research Organization (CRO) Designed to Help Address Chronically Under-Represented Ethnic Minorities in Clinical Research
Material Type:
Newspaper Article 		Add to My Research

Anaclim, LLC, A New Contract Research Organization (CRO) Designed to Help Address Chronically Under-Represented Ethnic Minorities in Clinical Research

Business Wire, 2005-11-30

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
4
Predix Pharmaceuticals Obtains Special Protocol Assessment for PRX-00023 Pivotal Study in Anxiety; Predix Also Initiates Phase Ib Clinical Trial for PRX-08066 in Pulmonary Arterial Hypertension
Predix Pharmaceuticals Obtains Special Protocol Assessment for PRX-00023 Pivotal Study in Anxiety; Predix Also Initiates Phase Ib Clinical Trial for PRX-08066 in Pulmonary Arterial Hypertension
Material Type:
Newspaper Article 		Add to My Research

Predix Pharmaceuticals Obtains Special Protocol Assessment for PRX-00023 Pivotal Study in Anxiety; Predix Also Initiates Phase Ib Clinical Trial for PRX-08066 in Pulmonary Arterial Hypertension

Business Wire, 2005-11-30

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
5
Alnylam Initiates Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
Alnylam Initiates Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
Material Type:
Newspaper Article 		Add to My Research

Alnylam Initiates Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection

Business Wire, 2005-12-07

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
6
Dyax and Genzyme Initiate Pivotal Phase III Trial of Subcutaneously Administered DX-88 for the Treatment of Hereditary Angioedema
Dyax and Genzyme Initiate Pivotal Phase III Trial of Subcutaneously Administered DX-88 for the Treatment of Hereditary Angioedema
Material Type:
Newspaper Article 		Add to My Research

Dyax and Genzyme Initiate Pivotal Phase III Trial of Subcutaneously Administered DX-88 for the Treatment of Hereditary Angioedema

Business Wire, 2005-12-08

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
7
NeoPharm Announces Completion of PRECISE Trial Enrollment as Per Special Protocol Assessment Agreement
NeoPharm Announces Completion of PRECISE Trial Enrollment as Per Special Protocol Assessment Agreement
Material Type:
Newspaper Article 		Add to My Research

NeoPharm Announces Completion of PRECISE Trial Enrollment as Per Special Protocol Assessment Agreement

Business Wire, 2005-12-09

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
8
FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus Gastroenteritis
FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus Gastroenteritis
Material Type:
Newspaper Article 		Add to My Research

FDA Vaccines Advisory Committee Unanimously Agrees That Clinical Data from 70,000-Infant Phase III Trials Support the Efficacy and Safety of ROTATEQ(R), Merck's Investigational Vaccine for Rotavirus Gastroenteritis

Business Wire, 2005-12-14

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
9
Alnylam Initiates Second Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection; Both U.S. and European Trials Now Underway
Alnylam Initiates Second Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection; Both U.S. and European Trials Now Underway
Material Type:
Newspaper Article 		Add to My Research

Alnylam Initiates Second Phase I Clinical Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection; Both U.S. and European Trials Now Underway

Business Wire, 2005-12-19

COPYRIGHT 2005 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
10
Knock-out Technologies' Ingestible Anti-Microbial Formula Kills Candida Species in Independent Laboratory Testing; Human Clinical Studies to Commence
Knock-out Technologies' Ingestible Anti-Microbial Formula Kills Candida Species in Independent Laboratory Testing; Human Clinical Studies to Commence
Material Type:
Newspaper Article 		Add to My Research

Knock-out Technologies' Ingestible Anti-Microbial Formula Kills Candida Species in Independent Laboratory Testing; Human Clinical Studies to Commence

Business Wire, 2006-01-03

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
11
BiovaxID(TM), Personalized Anti-Cancer Vaccine from Biovest International, Produces Long Term Clinical Remission and 95 Percent Overall Survival in Patients with Follicular Non-Hodgkin's Lymphoma in Phase 2 Clinical Trial
BiovaxID(TM), Personalized Anti-Cancer Vaccine from Biovest International, Produces Long Term Clinical Remission and 95 Percent Overall Survival in Patients with Follicular Non-Hodgkin's Lymphoma in Phase 2 Clinical Trial
Material Type:
Newspaper Article 		Add to My Research

BiovaxID(TM), Personalized Anti-Cancer Vaccine from Biovest International, Produces Long Term Clinical Remission and 95 Percent Overall Survival in Patients with Follicular Non-Hodgkin's Lymphoma in Phase 2 Clinical Trial

Business Wire, 2006-01-10

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
12
Clinical Data Initiates Pivotal Phase III Trial for Novel Antidepressant; First Ever Pharmacogenomic Screening Tool for Antidepressant to be Developed Concurrently
Clinical Data Initiates Pivotal Phase III Trial for Novel Antidepressant; First Ever Pharmacogenomic Screening Tool for Antidepressant to be Developed Concurrently
Material Type:
Newspaper Article 		Add to My Research

Clinical Data Initiates Pivotal Phase III Trial for Novel Antidepressant; First Ever Pharmacogenomic Screening Tool for Antidepressant to be Developed Concurrently

Business Wire, 2006-01-26

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
13
Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients with Cardiovascular Disease
Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients with Cardiovascular Disease
Material Type:
Newspaper Article 		Add to My Research

Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients with Cardiovascular Disease

Business Wire, 2006-02-02

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
14
The Uganda Virus Research Institute (UVRI), in collaboration with the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics, Launches HIV/AIDS Vaccine Trial in Entebbe, Uganda
The Uganda Virus Research Institute (UVRI), in collaboration with the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics, Launches HIV/AIDS Vaccine Trial in Entebbe, Uganda
Material Type:
Newspaper Article 		Add to My Research

The Uganda Virus Research Institute (UVRI), in collaboration with the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics, Launches HIV/AIDS Vaccine Trial in Entebbe, Uganda

Business Wire, 2006-02-06

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
15
Averion Inc. and SIPLAS Research Organization Inc. Sign Alliance Agreement for Complementary Promotion and Support of Clinical Trials
Averion Inc. and SIPLAS Research Organization Inc. Sign Alliance Agreement for Complementary Promotion and Support of Clinical Trials
Material Type:
Newspaper Article 		Add to My Research

Averion Inc. and SIPLAS Research Organization Inc. Sign Alliance Agreement for Complementary Promotion and Support of Clinical Trials

Business Wire, 2006-02-09

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
16
Rinat Neuroscience Selects invivodata's Electronic Patient Diary System for Use in Osteoarthritis Study
Rinat Neuroscience Selects invivodata's Electronic Patient Diary System for Use in Osteoarthritis Study
Material Type:
Newspaper Article 		Add to My Research

Rinat Neuroscience Selects invivodata's Electronic Patient Diary System for Use in Osteoarthritis Study

Business Wire, 2006-02-27

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
17
Geisinger Health System to Deploy Advanced Clinical Software's Study Manager(TM) to Manage Clinical Trials
Geisinger Health System to Deploy Advanced Clinical Software's Study Manager(TM) to Manage Clinical Trials
Material Type:
Newspaper Article 		Add to My Research

Geisinger Health System to Deploy Advanced Clinical Software's Study Manager(TM) to Manage Clinical Trials

Business Wire, 2006-03-01

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
18
Icagen Provides Update on Status of Enrollment in Pivotal Phase III Trial of ICA-17043
Icagen Provides Update on Status of Enrollment in Pivotal Phase III Trial of ICA-17043
Material Type:
Newspaper Article 		Add to My Research

Icagen Provides Update on Status of Enrollment in Pivotal Phase III Trial of ICA-17043

Business Wire, 2006-03-06

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
19
invivodata Announces the Industry's First Truly Global Electronic Patient Diary Solution; Exclusive Wireless Cradle Simplifies Data Uploads Across Global Clinical Trials
invivodata Announces the Industry's First Truly Global Electronic Patient Diary Solution; Exclusive Wireless Cradle Simplifies Data Uploads Across Global Clinical Trials
Material Type:
Newspaper Article 		Add to My Research

invivodata Announces the Industry's First Truly Global Electronic Patient Diary Solution; Exclusive Wireless Cradle Simplifies Data Uploads Across Global Clinical Trials

Business Wire, 2006-03-06

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by
20
ART Initiates Clinical Trials of the Softscan'R' System at Toronto's Princess Margaret Hospital as Part of North American Pivotal Study
ART Initiates Clinical Trials of the Softscan'R' System at Toronto's Princess Margaret Hospital as Part of North American Pivotal Study
Material Type:
Newspaper Article 		Add to My Research

ART Initiates Clinical Trials of the Softscan'R' System at Toronto's Princess Margaret Hospital as Part of North American Pivotal Study

Business Wire, 2006-03-22

COPYRIGHT 2006 Business Wire, Inc.

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 3,654  for All Library Resources

Sorted by: Sorted by: Date-oldestOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2008  (134)
  2. 2008 To 2011  (593)
  3. 2012 To 2015  (529)
  4. 2016 To 2020  (1,476)
  5. After 2020  (923)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait